Technical Analysis for MRNA - Moderna, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 348.83 | 7.84% | 25.35 |
MRNA closed up 7.84 percent on Friday, July 23, 2021, on 1.93 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 3
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Historical MRNA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | 7.84% | |
| Calm After Storm | Range Contraction | 7.84% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| New 52 Week High | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Up 1 ATR | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| Up 5% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/03/2021
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Nasdaq 100 Coronavirus Vaccine RNA Cancer Vaccine Cancer Vaccines Messenger RNA
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Nasdaq 100 Coronavirus Vaccine RNA Cancer Vaccine Cancer Vaccines Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 349.41 |
| 52 Week Low | 54.21 |
| Average Volume | 12,129,047 |
| 200-Day Moving Average | 152.81 |
| 50-Day Moving Average | 218.16 |
| 20-Day Moving Average | 259.21 |
| 10-Day Moving Average | 288.16 |
| Average True Range | 18.56 |
| ADX | 42.14 |
| +DI | 45.68 |
| -DI | 5.67 |
| Chandelier Exit (Long, 3 ATRs) | 293.73 |
| Chandelier Exit (Short, 3 ATRs) | 261.23 |
| Upper Bollinger Bands | 339.03 |
| Lower Bollinger Band | 179.39 |
| Percent B (%b) | 1.06 |
| BandWidth | 61.59 |
| MACD Line | 31.51 |
| MACD Signal Line | 22.25 |
| MACD Histogram | 9.2622 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 385.19 | ||||
| Resistance 3 (R3) | 381.34 | 365.38 | 379.13 | ||
| Resistance 2 (R2) | 365.38 | 356.12 | 367.30 | 377.11 | |
| Resistance 1 (R1) | 357.10 | 350.40 | 361.24 | 360.95 | 375.09 |
| Pivot Point | 341.14 | 341.14 | 343.21 | 343.06 | 341.14 |
| Support 1 (S1) | 332.86 | 331.88 | 337.00 | 336.71 | 322.57 |
| Support 2 (S2) | 316.90 | 326.16 | 318.82 | 320.55 | |
| Support 3 (S3) | 308.62 | 316.90 | 318.53 | ||
| Support 4 (S4) | 312.47 |
